TabletsTablets
Schedule H (Prescription Required)Overactive Bladder & AntispasmodicsCode: 2338

Oxybutynin Chloride 2.5mg Tablets

Generic Formulation:Oxybutynin Chloride 2.5mg Tablets
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹46.88
Brand Estimate*
₹127.72
Estimated Savings:₹80.84 (63% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Oxybutynin Chloride Tablets (2.5mg) is a classic synthetic tertiary amine antispasmodic and competitive muscarinic antagonist on the WHO Model List of Essential Medicines. It exerts a dual action: competitive antagonism of muscarinic M1, M2, and M3 receptors, plus a direct musculotropic papaverine-like relaxant effect on smooth muscle cells. Indicated for relief of symptoms of bladder instability associated with voiding in patients with neurogenic bladder (hyperreflexia), spina bifida, multiple sclerosis, and idiopathic overactive bladder.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2338.Report inaccuracy

Usage Guidelines

Take orally 2.5 mg to 5 mg two to three times daily with a full glass of water. Swallow whole. Can be taken with or without food.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Pronounced dry mouth, blurred vision, constipation, somnolence, dizziness, decreased sweating, flushing. Rare/Severe: Heat stroke (anhidrosis in hot climates), confusion/hallucinations in elderly, urinary retention, and glaucoma attacks.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

High incidence of central and peripheral anticholinergic side effects due to active metabolite N-desethyloxybutynin. Contraindicated in narrow-angle glaucoma, myasthenia gravis, obstructive uropathy, and paralytic ileus.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, nephrological diagnosis, or urological treatment recommendations. Always consult a registered nephrologist, urologist, or qualified medical practitioner before initiating, modifying, or discontinuing any kidney or urinary tract medication.